PhaseFocus has developed a series of patented computational imaging techniques that have a wide range of applications including live cell imaging, engineering metrology and electron microscopy. The Phasefocus Virtual Lens™ is a novel method for high-fidelity quantitative imaging and microscopy, known as ptychography. The company’s flagship product, Livecyte™, quantifies and compares dynamic live cell behaviour, an important area for stem cell and cancer research.
Braveheart owns 21.20% of the issued share capital in Phasefocus.
Find out more about PhaseFocus Holdings Limited